PUBLISHER: The Business Research Company | PRODUCT CODE: 1619671
PUBLISHER: The Business Research Company | PRODUCT CODE: 1619671
In vitro fertilization (IVF) devices and consumables refer to the specialized tools, equipment, and materials used in the process of in vitro fertilization, a medical procedure designed to assist with conception in cases of infertility. They are critical for ensuring the success of in vitro fertilization by providing the necessary tools and materials for each stage of the process, from egg retrieval and fertilization to embryo culture and transfer. These components are designed to create optimal conditions for fertilization and early embryonic development, ultimately increasing the chances of a successful pregnancy.
The main product types of in vitro fertilization (IVF) devices and consumables are instruments, accessories and disposables, and reagents and media. Instruments refer to the tools and devices used by healthcare professionals to perform various procedures, tests, and treatments. The technologies include fresh embryo in vitro fertilization (IVF), frozen embryo in vitro fertilization (IVF), and donor egg in vitro fertilization (IVF), and they are used by various end users such as fertility clinics, hospitals, surgical centers, and clinical research institutes.
The in vitro fertilization (IVF) devices and consumables market research report is one of a series of new reports from The Business Research Company that provides in vitro fertilization (IVF) devices and consumables market statistics, including in vitro fertilization (IVF) devices and consumables industry global market size, regional shares, competitors with a in vitro fertilization (IVF) devices and consumables market share, detailed in vitro fertilization (IVF) devices and consumables market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro fertilization (IVF) devices and consumables industry. This in vitro fertilization (IVF) devices and consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The in vitro fertilization (IVF) devices and consumables market size has XX (HCAGR) in recent years. It will grow from $2.29 billion in 2023 to $2.66 billion in 2024 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historic period can be attributed to rising infertility rates, greater awareness and acceptance of in vitro fertilization (IVF) treatments, an increase in gamete donations, growing government support and funding for infertility treatments, and a rise in delayed pregnancies.
The in vitro fertilization (IVF) devices and consumables market size is expected to see XX (FCAGR) in the next few years. It will grow to $4.88 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth during the forecast period can be attributed to the increased adoption of minimally invasive procedures, expanding healthcare infrastructure, the rise in fertility clinic expansions, growing use of personalized and precision medicine approaches in reproductive health, and higher disposable incomes. Key trends in the forecast period include the integration of artificial intelligence and machine learning, the development of innovative in vitro fertilization (IVF) consumables and devices, advancements in IVF technology such as preimplantation genetic testing and cryopreservation methods, advanced infertility treatments, and enhanced genetic screening.
Rising infertility rates are expected to drive the growth of the in vitro fertilization (IVF) devices and consumables market. Infertility is defined as the inability to conceive after one year of regular, unprotected intercourse or the inability to maintain a pregnancy. The increase in infertility rates is attributed to lifestyle changes, delayed pregnancies, and rising stress levels. IVF devices and consumables are utilized in assisted reproductive technologies to support the fertilization process, including equipment for egg retrieval, embryo culture, and embryo transfer, addressing infertility by facilitating successful conception and pregnancy. For example, in April 2023, the World Health Organization (WHO) reported that approximately 17.5% of the global adult population, or about 1 in 6 people, experience infertility at some point in their lives. In the U.S., around 11% of women and 9% of men of childbearing age face infertility issues. Specifically, about 19% of heterosexual women aged 15 to 49 who have never given birth experience infertility, while 6% of married women in this age group face infertility challenges. Consequently, the increasing rates of infertility are fueling the growth of the IVF devices and consumables market.
Leading companies in the in vitro fertilization (IVF) devices and consumables market are concentrating on creating innovative products, such as benchtop incubators for IVF clinics, to enhance embryo culture efficiency, success rates, and patient outcomes. A benchtop incubator for IVF clinics is a specialized piece of equipment designed to maintain a controlled environment for embryo culture and development during IVF procedures. These incubators are essential for providing precise conditions necessary for embryo growth, including temperature, humidity, and gas composition, such as oxygen and carbon dioxide levels. For example, in May 2022, Cook Group Incorporated, a US-based medical device company, introduced the MINC+(TM) Benchtop Incubator, an advanced version of the widely used MINC Mini Incubator, for IVF clinics in the US and Canada. The MINC+ features updated capabilities based on user feedback to enhance the experience for clinical embryologists. It includes the DishTrace platform, which combines touchscreen and PC software for comprehensive dish-data management. This system allows for tracking culture dishes as they are checked in and out of the incubator, monitors up to 50 MINC+ incubators simultaneously, and generates graphical histories and reports on MINC+ activity.
In July 2022, Esco Micro Pte. Ltd., a life sciences company based in Singapore, acquired Evidence Solutions for an undisclosed amount. This acquisition aligns with Esco's strategy for transformation and growth, aimed at leveraging its position to foster collaborations across global markets. Evidence Solutions, based in Denmark, specializes in in vitro fertilization (IVF) management technologies.
Major companies operating in the in vitro fertilization (IVF) devices and consumables market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, CooperSurgical Inc., Cook Medical Inc., Progyny Inc., Vitrolife AB, Esco Micro Pte. Ltd., Hamilton Thorne Ltd., Nantong Egens Biotechnology Co. Ltd., Genea Biomedx Pty Ltd., Kitazato Corporation, Fertility Center of Illinois, Rocket Medical PLC, Gynemed GmbH & Co. KG, Gynotek Ltd., Biocell Enterprise LLC, Laboratoire CCD, Invitrocare Ltd., Nidacon International AB
North America was the largest region in the in vitro fertilization (IVF) devices and consumables market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro fertilization (IVF) devices and consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the in vitro fertilization (IVF) devices and consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in vitro fertilization (IVF) devices and consumables market consists of sales of microscopes, culture media, and test tubes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In Vitro Fertilization (IVF) Devices And Consumables Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in vitro fertilization (IVF) devices and consumables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for in vitro fertilization (IVF) devices and consumables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro fertilization (IVF) devices and consumables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.